Citations (60)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sandro La Vignera, Antonio Aversa, Rossella Cannarella, Rosita A. Condorelli, Ylenia Duca, Giorgio I. Russo & Aldo E. Calogero. (2021) Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects. Expert Opinion on Pharmacotherapy 22:2, pages 179-189.
Read now
Read now
Andrea Russo, Paolo Capogrosso, Giovanni La Croce, Eugenio Ventimiglia, Luca Boeri, Alberto Briganti, Rocco Damiano, Francesco Montorsi & Andrea Salonia. (2016) Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasia. Expert Opinion on Drug Safety 15:12, pages 1661-1670.
Read now
Read now
Articles from other publishers (58)
Elisa Ventura-Aquino & Anders Ågmo. (2023) The elusive concept of sexual motivation: can it be anchored in the nervous system?. Frontiers in Neuroscience 17.
Crossref
Crossref
Marco Giandotti & Elena Vittoria Longhi. 2023. Managing Psychosexual Consequences in Chronic Diseases. Managing Psychosexual Consequences in Chronic Diseases
491
497
.
Robert S. Haber, Aditya K. Gupta, Edwin S. Epstein, J.L. Carviel & K.A. Foley. (2022) Finasteride for Androgenetic Alopecia Is Not Associated with Sexual Dysfunction: A Survey-Based, Single-Centre, Controlled Study. International Society of Hair Restoration Surgery 32:6, pages 209-212.
Crossref
Crossref
Didem YILMAZ ORAL & Serap GUR. (2022) İNTRAKAVERNOSAL SİLDENAFİLİN SIÇANLARDA DUTASTERID TEDAVİSİ SONRASI GELİŞEN EREKTIL DİSFONKSİYON ÜZERİNE YARARLI ETKİSİ. Ankara Universitesi Eczacilik Fakultesi Dergisi, pages 908-918.
Crossref
Crossref
Norhayati Mohamed Noor, Sana Umar, Azila Abdul-Aziz, Khalid Sheikh & Satyanarayana Somavarapu. (2022) Engineered Dutasteride-Lipid Based Nanoparticle (DST-LNP) System Using Oleic and Stearic Acid for Topical Delivery. Bioengineering 9:1, pages 11.
Crossref
Crossref
Claus G. Roehrborn & Daniel B. Rukstalis. (2022) Prostatic Urethral Lift Versus Medical Therapy: Examining the Impact on Sexual Function in Men with Benign Prostatic Hyperplasia. European Urology Focus 8:1, pages 217-227.
Crossref
Crossref
Vincenzo Favilla, Rossella Cannarella, Federica Trovato, Giovanni Li Volti, Alfio Distefano, Enrico Grimaldi, Giuseppa La Camera, Sandro La Vignera, Rosita A. Condorelli, Aldo E. Calogero & Sebastiano Cimino. (2021) Effects of dutasteride on sex hormones and cerebrospinal steroids in patients treated for benign prostatic hyperplasia. Endocrine 73:3, pages 712-718.
Crossref
Crossref
Antonio La Torre, Caterina Palleria, Irene Tamanini, Andrea Scardigli, Tommaso Cai, Manuela Colosimo, Lucia Muraca, Vincenzo Rania, Davida Mirra, Alessandro Casarella, Gianmarco Marcianò, Giovambattista De Sarro & Luca Gallelli. (2021) Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors. Uro 1:3, pages 82-98.
Crossref
Crossref
F. Borgo, A. D. Macandog, S. Diviccaro, E. Falvo, S. Giatti, G. Cavaletti & R. C. Melcangi. (2020) Alterations of gut microbiota composition in post-finasteride patients: a pilot study. Journal of Endocrinological Investigation 44:6, pages 1263-1273.
Crossref
Crossref
Osama A. Zitoun, Abdulrahman MN. Farhat, Mohamed A. Mohamed, Mohammad R. Hamad, Beatrice Aramini & Khawaja Husnain Haider. (2020) Management of benign prostate hyperplasia (BPH) by combinatorial approach using alpha-1-adrenergic antagonists and 5-alpha-reductase inhibitors. European Journal of Pharmacology 883, pages 173301.
Crossref
Crossref
Ahra Cho, Bilal Chughtai & Alexis E. Te. (2020) Benign Prostatic Hyperplasia and Male Lower Urinary Tract Symptoms: Epidemiology and Risk Factors. Current Bladder Dysfunction Reports 15:2, pages 60-65.
Crossref
Crossref
Dong-Wook Park, Hyo Serk Lee, Myeong-Seung Shim, Kyu Jin Yum & Ju Tae Seo. (2020)
Do Kimchi and
Cheonggukjang
Probiotics as a Functional Food Improve Androgenetic Alopecia? A Clinical Pilot Study
. The World Journal of Men's Health 38:1, pages 95.
Crossref
Crossref
. (2020) EFFECT OF A COMBINATION OF DUTASTERIDE AND PARENTERAL TESTOSTERONE UNDECANOATE ON TESTOSTERONE DEFICIENCY SYMPTOMS AND PROSTATE IN PATIENTS WITH TESTOSTERONE DEFICIENCY AND BENIGN PROSTATIC HYPERPLASIA. Journal of Men's Health 16:SP1, pages 35.
Crossref
Crossref
Abdulmaged M. Traish. (2020) Post-finasteride syndrome: a surmountable challenge for clinicians. Fertility and Sterility 113:1, pages 21-50.
Crossref
Crossref
Jorge Hallak, Thiago Afonso Teixeira & Guilherme Leme de Souza. 2020. Male Infertility. Male Infertility
455
468
.
R.S. Haber, A.K. Gupta, E. Epstein, J.L. Carviel & K.A. Foley. (2019) Finasteride for androgenetic alopecia is not associated with sexual dysfunction: a survey‐based, single‐centre, controlled study. Journal of the European Academy of Dermatology and Venereology 33:7, pages 1393-1397.
Crossref
Crossref
Robert S. Haber, Aditya K. Gupta, Edwin S. Epstein, J.L. Carviel & K.A. Foley. (2019) Finasteride for Androgenetic Alopecia Is Not Associated with Sexual Dysfunction: A Survey-Based, Single-Centre, Controlled Study. International Society of Hair Restoration Surgery 29:3, pages 89-96.
Crossref
Crossref
Roberto Frau & Marco Bortolato. (2019) Repurposing steroidogenesis inhibitors for the therapy of neuropsychiatric disorders: Promises and caveats. Neuropharmacology 147, pages 55-65.
Crossref
Crossref
Yu Seob Shin, Keshab Kumar Karna, Bo Ram Choi & Jong Kwan Park. (2019) Finasteride and Erectile Dysfunction in Patients with Benign Prostatic Hyperplasia or Male Androgenetic Alopecia. The World Journal of Men's Health 37:2, pages 157.
Crossref
Crossref
Jae Heon Kim, Min Jung Baek, Hwa Yeon Sun, Bora Lee, Shufeng Li, Yash Khandwala, Francesco Del Giudice & Benjamin I. Chung. (2018) Efficacy and safety of 5 alpha-reductase inhibitor monotherapy in patients with benign prostatic hyperplasia: A meta-analysis. PLOS ONE 13:10, pages e0203479.
Crossref
Crossref
J.S. Mervis, L.J. Borda & M. Miteva. (2018) ‘Post-finasteride syndrome’: what to tell our female patients?. British Journal of Dermatology 179:3, pages 785-786.
Crossref
Crossref
Abdulmaged M. Traish. (2018) The Post-finasteride Syndrome: Clinical Manifestation of Drug-Induced Epigenetics Due to Endocrine Disruption. Current Sexual Health Reports 10:3, pages 88-103.
Crossref
Crossref
Silvia Giatti, Silvia Diviccaro, Giancarlo Panzica & Roberto Cosimo Melcangi. (2018) Post-finasteride syndrome and post-SSRI sexual dysfunction: two sides of the same coin?. Endocrine 61:2, pages 180-193.
Crossref
Crossref
Mary K. Samplaski & Ajay K. Nangia. 2018. Encyclopedia of Reproduction. Encyclopedia of Reproduction
207
216
.
Norhayati Mohamed Noor, Khalid Sheikh, Satyanarayana Somavarapu & Kevin M.G. Taylor. (2017) Preparation and characterization of dutasteride-loaded nanostructured lipid carriers coated with stearic acid-chitosan oligomer for topical delivery. European Journal of Pharmaceutics and Biopharmaceutics 117, pages 372-384.
Crossref
Crossref
G. Corona, G. Tirabassi, D. Santi, E. Maseroli, M. Gacci, M. Dicuio, A. Sforza, E. Mannucci & M. Maggi. (2017) Sexual dysfunction in subjects treated with inhibitors of 5α-reductase for benign prostatic hyperplasia: a comprehensive review and meta-analysis. Andrology 5:4, pages 671-678.
Crossref
Crossref
Roberto Cosimo Melcangi, Daniele Santi, Roberto Spezzano, Maria Grimoldi, Tommaso Tabacchi, Maria Letizia Fusco, Silvia Diviccaro, Silvia Giatti, Giuseppe Carrà, Donatella Caruso, Manuela Simoni & Guido Cavaletti. (2017) Neuroactive steroid levels and psychiatric and andrological features in post-finasteride patients. The Journal of Steroid Biochemistry and Molecular Biology 171, pages 229-235.
Crossref
Crossref
Abdulmaged Traish, Karim Sultan Haider, Gheorghe Doros & Ahmad Haider. (2017) Long-term dutasteride therapy in men with benign prostatic hyperplasia alters glucose and lipid profiles and increases severity of erectile dysfunction. Hormone Molecular Biology and Clinical Investigation 30:3.
Crossref
Crossref
Bradley D. Anawalt. (2017) Is Dihydrotestosterone a Classic Hormone?. Endocrine Reviews 38:3, pages 170-172.
Crossref
Crossref
Ronald S. Swerdloff, Robert E. Dudley, Stephanie T. Page, Christina Wang & Wael A. Salameh. (2017) Dihydrotestosterone: Biochemistry, Physiology, and Clinical Implications of Elevated Blood Levels. Endocrine Reviews 38:3, pages 220-254.
Crossref
Crossref
N. Enatsu, K. Chiba, K. Sumii, T. Fukuda, K. Okada, K. Matsushita & M. Fujisawa. (2017) Dutasteride-mediated morphological changes in the genitourinary tract associated with altered expression patterns of the androgen and estrogen receptors in male rats. Andrology 5:2, pages 347-353.
Crossref
Crossref
Francisco J. Garcia, Eric Chung & Gerald Brock. 2017. Male Sexual Dysfunction. Male Sexual Dysfunction
172
193
.
Abdulmaged M. Traish. 2017. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity. Sex and Gender Factors Affecting Metabolic Homeostasis, Diabetes and Obesity
473
526
.
Charles Welliver & Ahmed Essa. (2016) Sexual Side Effects of Medical and Surgical Benign Prostatic Hyperplasia Treatments. Urologic Clinics of North America 43:3, pages 393-404.
Crossref
Crossref
Steven A. Kaplan, Jeannette Y. Lee, Alan G. Meehan & John W. Kusek. (2016) Time Course of Incident Adverse Experiences Associated with Doxazosin, Finasteride and Combination Therapy in Men with Benign Prostatic Hyperplasia: The MTOPS Trial. The Journal of Urology 195:6, pages 1825-1829.
Crossref
Crossref
Giovanni Corona. (2016) Editorial Comment on “Erectile and Ejaculatory Function Preserved With Convective Water Vapor Energy Treatment of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia: Randomized Controlled Study”. The Journal of Sexual Medicine 13:6, pages 934-935.
Crossref
Crossref
Giovanni Corona, Andrea M. Isidori, Antonio Aversa, Arthur L. Burnett & Mario Maggi. (2016) Endocrinologic Control of Men’s Sexual Desire and Arousal/Erection. The Journal of Sexual Medicine 13:3, pages 317-337.
Crossref
Crossref
Louis J. Gooren. 2016. Endocrinology: Adult and Pediatric. Endocrinology: Adult and Pediatric
2163
2176.e4
.
Jonathan Kiechle & Simon P. Kim. 2016. Prostate Cancer. Prostate Cancer
103
109
.
Abdulmaged M. Traish. (2015) The Impact of the 5α-Reductase Inhibitors (5α-RIs) on Male Sexual Function and Psychological Well-Being. Current Sexual Health Reports 7:4, pages 210-219.
Crossref
Crossref
Cara Tannenbaum. (2015) Associations Between Urinary Symptoms and Sexual Health in Older Adults. Clinics in Geriatric Medicine 31:4, pages 581-590.
Crossref
Crossref
Gillian L. Stearns & Jaspreet S. Sandhu. (2015) The Impact of Medical and Surgical Treatment for Benign Prostatic Hypertrophy on Erectile Function. Current Urology Reports 16:11.
Crossref
Crossref
Abdulmaged M. Traish, Karim Sultan Haider, Gheorghe Doros & Ahmad Haider. (2015) Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia. Hormone Molecular Biology and Clinical Investigation 23:3, pages 85-96.
Crossref
Crossref
Mary K. Samplaski & Ajay K. Nangia. (2015) Adverse effects of common medications on male fertility. Nature Reviews Urology 12:7, pages 401-413.
Crossref
Crossref
Ferdinando Fusco, Davide Arcaniolo, Massimiliano Creta, Gaetano Piccinocchi, Giovanni Arpino, Matteo Laringe, Roberto Piccinocchi, Nicola Longo, Paolo Verze, Francesco Mangiapia, Vittorio Imperatore & Vincenzo Mirone. (2014) Demographic and comorbidity profile of patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a real-life clinical setting: Are 5-alpha-reductase inhibitor consumers different?. World Journal of Urology 33:5, pages 685-689.
Crossref
Crossref
Thiagarajan Madheswaran, Rengarajan Baskaran, Pasupathi Sundaramoorthy & Bong Kyu Yoo. (2014) Enhanced skin permeation of 5α-reductase inhibitors entrapped into surface-modified liquid crystalline nanoparticles. Archives of Pharmacal Research 38:4, pages 534-542.
Crossref
Crossref
Dimitris Hatzichristou. 2015. Clinical Uro-Andrology. Clinical Uro-Andrology
65
116
.
Thomas R. Jarvis, Bilal Chughtai & Steven A. Kaplan. (2014) Bladder Outlet Obstruction and BPH. Current Bladder Dysfunction Reports 9:4, pages 372-378.
Crossref
Crossref
Charles Welliver, Michael Butcher, Yogitha Potini & Kevin T. McVary. (2014) Impact of Alpha Blockers, 5-alpha Reductase Inhibitors and Combination Therapy on Sexual Function. Current Urology Reports 15:10.
Crossref
Crossref
Su Kil Jang & Seong Soo Joo. (2014) Promotional effects of Sargassum fusiforme fractions on hair growth via in vitro and in vivo models. Journal of Biomedical Research 15:2, pages 72-77.
Crossref
Crossref
Jun Ho Lee. (2014) Associations Between Premature Ejaculation, Lower Urinary Tract Symptoms, and Erectile Dysfunction in Middle‐Aged Korean Policemen. The Journal of Sexual Medicine 11:6, pages 1512-1518.
Crossref
Crossref
Alessandro Pizzocaro, Giovanna Motta, Luciano Negri & Pierpaolo Graziotti. (2014) Sindrome post-finasteride: tra mito e realtà. L'Endocrinologo 15:3, pages 112-117.
Crossref
Crossref
Thiagarajan Madheswaran, Rengarajan Baskaran, Chul Soon Yong & Bong Kyu Yoo. (2013) Enhanced Topical Delivery of Finasteride Using Glyceryl Monooleate-Based Liquid Crystalline Nanoparticles Stabilized by Cremophor Surfactants. AAPS PharmSciTech 15:1, pages 44-51.
Crossref
Crossref
Abdulmaged M. TraishAshwini MulgaonkarNicholas Giordano. (2014) The Dark Side of 5α-Reductase Inhibitors' Therapy: Sexual Dysfunction, High Gleason Grade Prostate Cancer and Depression. Korean Journal of Urology 55:6, pages 367.
Crossref
Crossref
Mark A. MoyadMark A. Moyad. 2014. Complementary & Alternative Medicine for Prostate and Urologic Health. Complementary & Alternative Medicine for Prostate and Urologic Health
67
87
.
Carlos Balmori. (2013) Alfabloqueantes: efectos en la mejora de la disfunción eréctil y el deseo sexual en pacientes con hipertrofia prostática benigna. Revista Internacional de Andrología 11:4, pages 123-127.
Crossref
Crossref
Yasmeen Kabir & Carolyn Goh. (2013) Androgenetic alopecia. Journal of the Egyptian Womenʼs Dermatologic Society 10:3, pages 107-116.
Crossref
Crossref
Donghua Xie, Bilal Chughtai, Dean S. Elterman, Stephan Seklehner, Richard Lee, Alexis E. Te & Steven A. Kaplan. (2013) The Link Between Benign Prostatic Hyperplasia and Sexual Dysfunction. Current Bladder Dysfunction Reports 8:3, pages 229-235.
Crossref
Crossref